# An Exploratory Sub-study for the RED-HF™ (Reduction of Events With Darbepoetin Alfa in Heart Failure) Trial

> **NCT00534456** · PHASE3 · TERMINATED · sponsor: **Amgen** · enrollment: 12 (actual)

## Conditions studied

- Anemia
- Cardiovascular Disease
- Congestive Heart Failure
- Heart Failure
- Ventricular Dysfunction

## Interventions

- **DRUG:** Placebo
- **DRUG:** Darbepoetin alfa

## Key facts

- **NCT ID:** NCT00534456
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-01
- **Primary completion:** 2007-10
- **Final completion:** 2007-10
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Study terminated
- **Last updated:** 2011-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00534456

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00534456, "An Exploratory Sub-study for the RED-HF™ (Reduction of Events With Darbepoetin Alfa in Heart Failure) Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00534456. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*